ATE504301T1 - Verwendung von natriumblockern zur frühzeitigen behandlung von obstruktiven lungenerkrankungen - Google Patents
Verwendung von natriumblockern zur frühzeitigen behandlung von obstruktiven lungenerkrankungenInfo
- Publication number
- ATE504301T1 ATE504301T1 AT08700996T AT08700996T ATE504301T1 AT E504301 T1 ATE504301 T1 AT E504301T1 AT 08700996 T AT08700996 T AT 08700996T AT 08700996 T AT08700996 T AT 08700996T AT E504301 T1 ATE504301 T1 AT E504301T1
- Authority
- AT
- Austria
- Prior art keywords
- lung disease
- obstructive lung
- early treatment
- sodium
- blockers
- Prior art date
Links
- 208000011623 Obstructive Lung disease Diseases 0.000 title abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title 1
- 229910052708 sodium Inorganic materials 0.000 title 1
- 239000011734 sodium Substances 0.000 title 1
- 108010052164 Sodium Channels Proteins 0.000 abstract 1
- 102000018674 Sodium Channels Human genes 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000002919 epithelial cell Anatomy 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07000267A EP1941883A1 (de) | 2007-01-08 | 2007-01-08 | Verwendung von Natriumblockern zur frühzeitigen Behandlung von obstruktiven Lungenerkrankungen |
| PCT/EP2008/000051 WO2008083942A1 (en) | 2007-01-08 | 2008-01-07 | Use of sodium blockers for an early therapy of obstructive lung diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE504301T1 true ATE504301T1 (de) | 2011-04-15 |
Family
ID=38093414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08700996T ATE504301T1 (de) | 2007-01-08 | 2008-01-07 | Verwendung von natriumblockern zur frühzeitigen behandlung von obstruktiven lungenerkrankungen |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20090312348A1 (de) |
| EP (2) | EP1941883A1 (de) |
| AT (1) | ATE504301T1 (de) |
| DE (1) | DE602008006024D1 (de) |
| WO (1) | WO2008083942A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201922239A (zh) * | 2017-10-04 | 2019-06-16 | 英商尼姆生物技術有限公司 | 藥學組成物及其用途 |
| WO2023275622A2 (en) * | 2021-07-01 | 2023-01-05 | Aquapass Ltd | Methods and devices for modulating electrolyte excretion |
| CN116211863B (zh) * | 2023-03-15 | 2025-07-18 | 山东大学 | 阿米洛利在制备防治感染性心内膜炎或抑制其病原菌药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4501729A (en) * | 1982-12-13 | 1985-02-26 | Research Corporation | Aerosolized amiloride treatment of retained pulmonary secretions |
| KR930701992A (ko) * | 1990-10-05 | 1993-09-08 | 웨인 알.조운즈 | 환자의 폐에 잔존하는 점액 분비물의 제거 방법 |
| JP4633927B2 (ja) * | 1998-05-22 | 2011-02-16 | インスパイアー ファーマシューティカルズ,インコーポレイティド | 治療用ジヌクレオチドおよび誘導体 |
| CA2575670A1 (en) * | 2004-08-18 | 2006-03-02 | Michael R. Johnson | Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
-
2007
- 2007-01-08 EP EP07000267A patent/EP1941883A1/de not_active Withdrawn
-
2008
- 2008-01-07 US US12/522,369 patent/US20090312348A1/en not_active Abandoned
- 2008-01-07 DE DE602008006024T patent/DE602008006024D1/de active Active
- 2008-01-07 AT AT08700996T patent/ATE504301T1/de not_active IP Right Cessation
- 2008-01-07 WO PCT/EP2008/000051 patent/WO2008083942A1/en not_active Ceased
- 2008-01-07 EP EP08700996A patent/EP2114407B1/de not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| US20090312348A1 (en) | 2009-12-17 |
| EP2114407A1 (de) | 2009-11-11 |
| DE602008006024D1 (de) | 2011-05-19 |
| EP1941883A1 (de) | 2008-07-09 |
| EP2114407B1 (de) | 2011-04-06 |
| WO2008083942A1 (en) | 2008-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201000105A1 (ru) | Химические соединения | |
| EA201100255A1 (ru) | 5-алкинилпиримидины | |
| EA201071144A1 (ru) | Гетероциклические производные | |
| CU20110119A7 (es) | Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hematológicas | |
| EA201270666A1 (ru) | Соединения и фармацевтические композиции для снижения уровня мочевой кислоты | |
| EA200802213A1 (ru) | Способы лечения заболеваний крови | |
| EA201100254A1 (ru) | Новые соединения | |
| EA200702387A1 (ru) | Имидазохинолины в качестве ингибиторов липидкиназы | |
| CY1112320T1 (el) | Τιτλοδοτηση της ταπενταδολης | |
| GT201200164A (es) | "nuevos compuestos de espiropiperidina" | |
| GB2496794A (en) | Combination pharmaceutical composition and methods of treating and methods of treating functional diseases or conditions of gastrointestinal tract | |
| EA201400521A1 (ru) | Гетероциклические соединения, лекарственные средства, содержащие указанные соединения, их применение и способы их получения | |
| MY153408A (en) | Novel methods | |
| MY137477A (en) | Substituted oxazole-benzoisothiazole dioxide derivatives, process for their preparation and their use | |
| MX2009006913A (es) | Uso de derivados de acido de piranona sustituidos para el tratamiento del sindrome metabolico. | |
| WO2011113507A3 (en) | Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns | |
| BR112014008783A2 (pt) | compostos para o tratamento e profilaxia da doença causada por vírus sincicial respiratório | |
| EA201001427A1 (ru) | Тиазолилдигидроиндазолы | |
| ATE504301T1 (de) | Verwendung von natriumblockern zur frühzeitigen behandlung von obstruktiven lungenerkrankungen | |
| EA201390417A1 (ru) | Антидиабетические твердые фармацевтические композиции | |
| EA201101517A1 (ru) | 5-алкинилпиридины | |
| DOP2010000156A (es) | Oxazolidinonas para el tratamiento y/o profilaxis de la insuficiencia cardiaca | |
| EA200900269A1 (ru) | Лекарственные комбинации для лечения заболеваний дыхательных путей | |
| EA201390925A1 (ru) | Производные санглиферина и способы их получения | |
| MX2010000120A (es) | Estereoisomeros de triciclodecan-9-il-xantogenato. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |